Additionally, OC’s previously demonstrated ability to stabilize collagen type II alpha 1 chain (COL2A1) expression in OA chondrocytes [150] may hold relevance in CHS, where ECM remodeling and collagen mutations create an immunosuppressive tumor niche enriched in M2 macrophages [134]. The gene discussed is COL2A1; the disease is neoplasm.